Price
Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.
Smart Score
AverageThe Company is a contract development and manufacturing organization that specializes in single-use and single-patient medical devices. The Company is a vital link in the medical device supply chain and a valued outsourcing partner to many of the world's top medical device manufacturers. Our single-use and single-patient devices and components are used in a wide range of medical devices and packaging for minimally invasive surgery, infection prevention, wound care, wearables, orthopedic soft goods, and orthopedic implants.
In the company’s own words · 10-K filed Feb 27, 2026 · SEC EDGAR
Business segments
Q2 2026 · $1.5MThe company’s own SEC segment disclosure.
- Engineering And Development$1.0M69%
- Tooling And Machinery$448.0K31%
UFP Technologies, Inc. (UFPT) reported revenue of $154M in Q1 2026 (quarter ended March 31, 2026), up 4.1% from the same quarter a year earlier. That came with a gross margin of 29% and net income of $17M (11% of revenue). For the full year FY2025, revenue was $603M (+20% year on year) and net income $68M. Its largest product in 2026-Q2 was Engineering And Development at $1.0M, 69% of the disclosed total, just ahead of Tooling And Machinery at 31%.
Raw charts
11 series · TTMAs reported to the SEC, without any scoring.